title: Can Botulinum Toxin Help Patients With Borderline Personality Disorder?
authors: From the Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Hannover, Germany; Dell Medical School, University of Texas at Austin; and Asklepios Clinic North-Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis University, Germany.
authors: Tillmann H C
authors: TH
authors: Kruger
authors: From the Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Hannover, Germany; Dell Medical School, University of Texas at Austin; and Asklepios Clinic North-Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis University, Germany.
authors: Michelle
authors: M
authors: Magid
authors: From the Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Hannover, Germany; Dell Medical School, University of Texas at Austin; and Asklepios Clinic North-Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis University, Germany.
authors: M Axel
authors: MA
authors: Wollmer
mesh_terms: D000328:Adult; D001883:Borderline Personality Disorder / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D005145:Face; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D019274:Botulinum Toxins, Type A
keywords: Borderline Personality Disorder; Drugs-New; Women